Literature DB >> 25524790

The impact of case definition on attention-deficit/hyperactivity disorder prevalence estimates in community-based samples of school-aged children.

Robert E McKeown1, Joseph R Holbrook2, Melissa L Danielson2, Steven P Cuffe3, Mark L Wolraich4, Susanna N Visser5.   

Abstract

OBJECTIVE: To determine the impact of varying attention-deficit/hyperactivity disorder (ADHD) diagnostic criteria, including new DSM-5 criteria, on prevalence estimates.
METHOD: Parent and teacher reports identified high- and low-screen children with ADHD from elementary schools in 2 states that produced a diverse overall sample. The parent interview stage included the Diagnostic Interview Schedule for Children-IV (DISC-IV), and up to 4 additional follow-up interviews. Weighted prevalence estimates, accounting for complex sampling, quantified the impact of varying ADHD criteria using baseline and the final follow-up interview data.
RESULTS: At baseline 1,060 caregivers were interviewed; 656 had at least 1 follow-up interview. Teachers and parents reported 6 or more ADHD symptoms for 20.5% (95% CI = 18.1%-23.2%) and 29.8% (CI = 24.5%-35.6%) of children respectively, with criteria for impairment and onset by age 7 years (DSM-IV) reducing these proportions to 16.3% (CI = 14.7%-18.0%) and 17.5% (CI = 13.3%-22.8%); requiring at least 4 teacher-reported symptoms reduced the parent-reported prevalence to 8.9% (CI = 7.4%-10.6%). Revising age of onset to 12 years per DSM-5 increased the 8.9% estimate to 11.3% (CI = 9.5%-13.3%), with a similar increase seen at follow-up: 8.2% with age 7 onset (CI = 5.9%-11.2%) versus 13.0% (CI = 7.6%-21.4%) with onset by age 12. Reducing the number of symptoms required for those aged 17 and older increased the overall estimate to 13.1% (CI = 7.7%-21.5%).
CONCLUSION: These findings quantify the impact on prevalence estimates of varying case definition criteria for ADHD. Further research of impairment ratings and data from multiple informants is required to better inform clinicians conducting diagnostic assessments. DSM-5 changes in age of onset and number of symptoms required for older adolescents appear to increase prevalence estimates, although the full impact is uncertain due to the age of our sample. Published by Elsevier Inc.

Entities:  

Keywords:  ADHD; DSM-5; age of onset; diagnostic criteria; impairment

Mesh:

Year:  2014        PMID: 25524790      PMCID: PMC4472453          DOI: 10.1016/j.jaac.2014.10.014

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  30 in total

1.  NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.

Authors:  D Shaffer; P Fisher; C P Lucas; M K Dulcan; M E Schwab-Stone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

2.  Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population.

Authors:  Jennifer L Vande Voort; Jian-Ping He; Nicole D Jameson; Kathleen R Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-04-23       Impact factor: 8.829

3.  Implications of changes for the field: ADHD.

Authors:  Margaret H Sibley; James G Waxmonsky; Jessica A Robb; William E Pelham
Journal:  J Learn Disabil       Date:  2012-11-05

4.  Characteristics of DSM-IV attention deficit hyperactivity disorder combined and predominantly inattentive subtypes in a Turkish clinical sample.

Authors:  Ozgur Oner; Pinar Oner; Esra Cop; Kerim M Munir
Journal:  Child Psychiatry Hum Dev       Date:  2012-08

Review 5.  Epidemiology of mental disorders in primary care settings.

Authors:  D Goldberg
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

Review 6.  ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.

Authors:  Guilherme V Polanczyk; Erik G Willcutt; Giovanni A Salum; Christian Kieling; Luis A Rohde
Journal:  Int J Epidemiol       Date:  2014-01-24       Impact factor: 7.196

7.  Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?

Authors:  Natalie Grizenko; Michael Paci; Ridha Joober
Journal:  J Atten Disord       Date:  2009-09-18       Impact factor: 3.256

8.  Impaired but undiagnosed.

Authors:  A Angold; E J Costello; E M Farmer; B J Burns; A Erkanli
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-02       Impact factor: 8.829

9.  Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

Authors:  Mark L Wolraich; Warren Lambert; Melissa A Doffing; Leonard Bickman; Tonya Simmons; Kim Worley
Journal:  J Pediatr Psychol       Date:  2003-12

Review 10.  The proposed changes for DSM-5 for SLD and ADHD: international perspectives--Australia, Germany, Greece, India, Israel, Italy, Spain, Taiwan, United Kingdom, and United States.

Authors:  Michal Al-Yagon; Wendy Cavendish; Cesare Cornoldi; Angela J Fawcett; Matthias Grünke; Li-Yu Hung; Juan E Jiménez; Sunil Karande; Christina E van Kraayenoord; Daniela Lucangeli; Malka Margalit; Marjorie Montague; Rukhshana Sholapurwala; Georgios Sideridis; Patrizio E Tressoldi; Claudio Vio
Journal:  J Learn Disabil       Date:  2013 Jan-Feb
View more
  11 in total

1.  Academic and Social Functioning Associated with Attention-Deficit/Hyperactivity Disorder: Latent Class Analyses of Trajectories from Kindergarten to Fifth Grade.

Authors:  George J DuPaul; Paul L Morgan; George Farkas; Marianne M Hillemeier; Steve Maczuga
Journal:  J Abnorm Child Psychol       Date:  2016-10

2.  Addressing Discrepancies Between ADHD Prevalence and Case Identification Estimates Among U.S. Children Utilizing NSCH 2007-2012.

Authors:  MinKyoung Song; Nathan F Dieckmann; Joel T Nigg
Journal:  J Atten Disord       Date:  2018-09-28       Impact factor: 3.256

3.  Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016.

Authors:  Melissa L Danielson; Rebecca H Bitsko; Reem M Ghandour; Joseph R Holbrook; Michael D Kogan; Stephen J Blumberg
Journal:  J Clin Child Adolesc Psychol       Date:  2018-01-24

4.  Interpreting the Prevalence of Mental Disorders in Children: Tribulation and Triangulation.

Authors:  Joseph R Holbrook; Rebecca H Bitsko; Melissa L Danielson; Susanna N Visser
Journal:  Health Promot Pract       Date:  2016-11-16

5.  ADHD and Vision Problems in the National Survey of Children's Health.

Authors:  Dawn K DeCarlo; Mark Swanson; Gerald McGwin; Kristina Visscher; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2016-05       Impact factor: 1.973

6.  Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade.

Authors:  Michael Davidovitch; Gideon Koren; Naama Fund; Maayan Shrem; Avi Porath
Journal:  BMC Pediatr       Date:  2017-12-29       Impact factor: 2.125

Review 7.  ADHD prevalence estimates in Italian children and adolescents: a methodological issue.

Authors:  Laura Reale; Maurizio Bonati
Journal:  Ital J Pediatr       Date:  2018-09-05       Impact factor: 2.638

8.  Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review.

Authors:  Luise Kazda; Katy Bell; Rae Thomas; Kevin McGeechan; Alexandra Barratt
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

9.  Community-Based Prevalence of Externalizing and Internalizing Disorders among School-Aged Children and Adolescents in Four Geographically Dispersed School Districts in the United States.

Authors:  Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Sana N Charania; Angelika H Claussen; Robert E McKeown; Steven P Cuffe; Julie Sarno Owens; Steven W Evans; Lorraine Kubicek; Kate Flory
Journal:  Child Psychiatry Hum Dev       Date:  2021-06

10.  A review of changes to the attention deficit/hyperactivity disorder age of onset criterion using the checklist for modifying disease definitions.

Authors:  Sharon Sanders; Rae Thomas; Paul Glasziou; Jenny Doust
Journal:  BMC Psychiatry       Date:  2019-11-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.